Indaptus Therapeutics (INDP) Short-term Investments (2021 - 2026)

Indaptus Therapeutics' Short-term Investments history runs 3 years deep, the most recent figure standing at $7.0 million for Q2 2023.

• In Q2 2023, Short-term Investments fell 62.71% year-over-year to $7.0 million; the TTM figure through Jun 2023 stood at $7.0 million (down 62.71% YoY), while the FY2022 annual figure was $16.8 million, changed N/A from the prior year.
• Short-term Investments for Q2 2023 stood at $7.0 million, down from $14.9 million in the prior quarter.
• The five-year high for Short-term Investments was $21.7 million in Q3 2022, with the low at $1.0 million in Q1 2021.
• The 3-year median for Short-term Investments is $10.9 million (2023), against an average of $10.5 million.
• The sharpest annual moves came in 2022 and 2023: Short-term Investments soared 1775.31% in 2022, then tumbled 62.71% in 2023.
• Indaptus Therapeutics' Short-term Investments stood at $1.0 million in 2021, then surged by 1580.6% to $16.8 million in 2022, then tumbled by 58.39% to $7.0 million in 2023.
• Business Quant data shows INDP's Short-term Investments at $7.0 million in Q2 2023, $14.9 million in Q1 2023, and $16.8 million in Q4 2022.